Cargando…
Frequency of heterozygous TET2 deletions in myeloproliferative neoplasms
The Philadelphia chromosome (Ph)-negative myeloproliferative neoplasms (MPNs), including polycythemia vera, essential thrombocythemia, and primary myelofibrosis, are a group of clonal hematopoietic stem cell disorders with overlapping clinical and cytogenetic features and a variable tendency to evol...
Autores principales: | Tripodi, Joseph, Hoffman, Ronald, Najfeld, Vesna, Weinberg, Rona |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004566/ https://www.ncbi.nlm.nih.gov/pubmed/21188113 http://dx.doi.org/10.2147/CMR.S12829 |
Ejemplares similares
-
Characterization of disease-propagating stem cells responsible for myeloproliferative neoplasm–blast phase
por: Wang, Xiaoli, et al.
Publicado: (2022) -
Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms
por: Lasho, Terra L., et al.
Publicado: (2018) -
p53 as a target in myeloproliferative neoplasms
por: Lu, Min, et al.
Publicado: (2012) -
JAK2 Exon 14 Deletion in Patients with Chronic Myeloproliferative Neoplasms
por: Ma, Wanlong, et al.
Publicado: (2010) -
Targeting CHAF1B Enhances IFN Activity against Myeloproliferative Neoplasm Cells
por: Saleiro, Diana, et al.
Publicado: (2023)